Template:CMV retinitis treatment: Difference between revisions
Ostermayer (talk | contribs) (Created page with "===Severe Vision Threatening=== *Ganciclovir intraocular implant for 8 months AND **Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days ===Periphera...") |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
===Severe Vision Threatening=== | ====Severe Vision Threatening==== | ||
*Ganciclovir intraocular implant for 8 months AND | *Ganciclovir intraocular implant for 8 months AND | ||
**Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days | **Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days | ||
===Peripheral lesions=== | ====Peripheral lesions==== | ||
*Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days | *Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days | ||
Latest revision as of 15:46, 29 April 2015
Severe Vision Threatening
- Ganciclovir intraocular implant for 8 months AND
- Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days
Peripheral lesions
- Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days